粘液性乳腺癌的临床研究进展

doi:10.11904/j.issn.1002-3070.2020.04.016

Abstract

Abstract: Mucinous breast cancer(MBC)is an aggressive tumor from the breast.It is not a common type of breast cancer,and the literature about mucinous breast cancer is relatively rare.Based on the cellular composition of the tumor,mucinous breast cancer is divided into two subtypes: pure type mucinous cancer(PMBC)and mixed type mucinous breast cancer(MMBC).This article reviews the clinical characteristics,immunophenotype,genomics,differential diagnosis,treatment,and prognosis of mucinous breast cancer.

Key words: Mucinous breast cancer, Clinical characteristics, Immunophenotype, Differential diagnosis, Treatment

CLC Number:

R737.9

ZHANG Rui, LI Zhigao. Clinical research progress of mucinous breast cancer[J]. Journal of Practical Oncology, 2020, 34(4): 377-381.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2020.04.016

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2020/V34/I4/377

References

1 Di S,Gutierrez J,Avisar E.A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma[J].Breast Cancer Res Treat,2008,111(3):541-547.
2 Bae SY,Choi MY,Cho DH,et al.Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma:clinicopathologic characteristics and prognosis[J].Breast Cancer,2011,14(4):308-313.
3 Komaki K,Sakamoto G,Sugano H,et al.Mucinous carcinoma of the breast in Japan:a prognostic analysis based on morphologic features[J].Cancer,1988,61(5):989-996.
4 Cao AY,He M,Liu ZB,et al.Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma:a population-based study from China[J].Ann Surg Oncol,2012,19(9):3019-3027.
5 刘强,姚海东,林娇卡.乳腺黏液腺癌X线摄影表现与病理对照分析[J].医学影像学杂志,2014,24(2):218-221.
6 Naqos N,Naim A,Jouhadi H,et al.Mucinous carcinoma of the breast:clinical,biological and evolutive profile[J].Cancer Radiother,2016,20(8):801-804.
7 Zhang H,Qiu L,Peng Y.The sonographic findings of micropapillary pattern in pure mucinous carcinoma of the breast[J].World J Surg Oncol,2018,16(1):151.
8 Qu N,Luo Y,Yu T,et al.Differentiation between pure mucinous breast carcinomas and fibroadenomas with strong high-signal intensity on T2-weighted images from dynamic contrast-enhanced magnetic resonance imaging[J].Breast Care(Basel),2018,13(1):32-37.
9 Conant EF,Dillon RL,Palazzo J,et al.Imaging findings in mucin-containing carcinomas of the breast:correlation with pathologic features[J].AJR Am J Roentgenol,2013,163(4):821-824.
10 Chaudhry AR,Khoury M,Gotra A,et al.Imaging features of pure and mixed forms of mucinous breast carcinoma with histopathological correlation[J].Br J Radiol,2019,92(1095):810.
11 Barkley CR,Ligibel JA,Wong JS,et al.Mucinous breast carcinoma:a large contemporary series[J].Am J Surg,2008,196(4):549-551.
12 Harrison BT,Dillon DA.An update of mucinous lesions of the breast[J].Surg Pathol Clin,2018,11(1):61-90.
13 Patel S,Bhanu S,Mehta N,et al.Invasive colloid carcinoma and the role of ki67 and her2-two case reports[J].Radiol Case Rep,2018,14(3):337-342.
14 Garcia H,Canavati M,Garza M,et al.Her-2 positive mucinous carcinoma breast cancer,case report[J].Int J Surg Case Rep,2018,42(12):242-246.
15 De A,Derchain SF,Pavanello M,et al.Expression of unusual immunohistochemical markers in mucinous breast carcinoma[J].Acta Histochem,2017,119(3):327-336.
16 Rosen LE,Gattuso P.Neuroendocrine tumors of the breast[J].Arch Pathol Lab Med,2017,141(11):1577-1581.
17 Garcia L,Garza R,Barboza O,et al.Cdx-2,muc-2 and b-catenin as intestinal markers in pure mucinous carcinoma of the breast[J].Biol Res,2014,47(1):43.
18 Pareja F,Lee JY,Brown DN,et al.The genomic landscape of mucinous breast cancer[J].Natl Cancer Inst,2019,111(7):216.
19 Lacroix M,Suarez PH,MacKay A,et al.Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type[J].Pathol,2010,222(3):282-298.
20 Artibani M,Sims AH,Slight J,et al.Wt1 expression in breast cancer disrupts the epithelial mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel[J].Sci Rep,2017,27(7):45255.
21 Domfeh AB,Carley AL,Striebel JM,et al.Wt1 immunoreactivity in breast carcinoma:selective expression in pure and mixed mucinous subtypes[J].Mod Pathol,2008,21(10):1217-1223.
22 Heng C,Wei T,Yingbing T,et al.Clinicopathological characteristics of breast sebaceous adenocarcinoma[J].Pol J Pathol,2018,69(3):226-233.
23 Svajdler M,Banik P,Poliakova K,et al.Sebaceous carcinoma of the breast:report of four cases and review of the literature[J].Pol J Pathol,2015,66(2):142-148.
24 Darcy C,Quinn C.Apocrine lesions of the breast:part 1 of a two-part review:benign,atypical and in situ apocrine proliferations of the breast[J].Clin Pathol,2019,72(1):1-6.
25 Guo SP,Li QL,Wang YM,et al.Clinicopathologic features of adenoid cystic carcinoma of breast[J].Zhonghua Bing Li Xue Za Zhi,2017,46(1):25-29.
26 Limite G,Di R,Esposito E,et al.Acinic cell carcinoma of the breast:review of the literature[J].Int J Surg,2014,12(1):35-39.
27 Reyes C,Nadji M.The immunophenotype of nodular variant of medullary carcinoma of the breast[J].Appl Immunohistochem Mol Morphol,2015,23(9):624-627.
28 Liu H,Tan H,Cheng Y,et al.Imaging findings in mucinous breastcarcinoma and correlating factors[J].Eur J Radiol,2011,80(3):706-712.
29 Goto W,Kashiwagi S,Takada K,et al.A case of multiple lung metastases from breast cancer successfully treated with endocrine therapy[J].Gan To Kagaku Ryoho,2018,45(13):2426-2428.
30 Jang Y,Cho EY,Cho SY.Human epidermal growth factor receptor 2-positive mucinous carcinoma with signet ring cell differentiation,which showed complete response after neoadjuvant chemotherapy[J].Breast Cancer,2019,22(2):336-340.
31 Seki H,Sakurai T,Maeda Y,et al.Efficacy and safety of palbociclib and fulvestrant in Japanese patients with er+/her2-advanced metastatic breast cancer[J].In Vivo,2019,33(6):2037-2044.
32 Dill EA,Gru AA,Atkins KA,et al.PD-L1 expression and intratumoral heterogeneity across breast cancer subtypes and stages:an assessment of 245 primary and 40 metastatic tumors[J].Am J Surg Pathol,2017,41(3):334-342.
33 Zhang M,Teng XD,Guo XX,et al.Clinicopathological characteristics and prognosis of mucinous breast carcinoma[J].Cancer Res Clin Oncol,2014,140(2):265-269.
34 Skotnicki P,Sas-Korczynska B,Strzepek L,et al.Pure and mixed mucinous carcinoma of the breast:a comparison of clinical outcomes and treatment results[J].Breast J,2016,22(5):529-534.

[1]	LI Hui,PANG Da. Clinicopathological characteristics and adjuvant treatment of triple positive breast cancer [J]. Journal of Practical Oncology, 2020, 34(3): 262-265.
[2]	LU Xuemei,LI Yuntao,AN Jinhui,JI Guozhong. The mechanism of lysophosphatidic acid in the development of colorectal cancer [J]. Journal of Practical Oncology, 2020, 34(3): 276-281.
[3]	HAN Shuling, FANG Lin, ZHANG Yanqiao. Thoughts on the diagnosis and treatment of patients with oncology after the corona virus disease 2019 epidemic [J]. Journal of Practical Oncology, 2020, 34(2): 97-99.
[4]	SU Wenjia, WANG Shuye. Prognostic stratification and treatment progress of follicular lymphoma [J]. Journal of Practical Oncology, 2020, 34(2): 189-192.
[5]	ZHANG Jinglan, LIU Ruibao. Progress in local interventional therapy for colorectal cancer with liver metastasis [J]. Journal of Practical Oncology, 2020, 34(1): 79-82.
[6]	CAO Shu, LI Shasha, YANG Dan. Advances in research of signaling pathway-related microRNA in osteosarcoma [J]. Journal of Practical Oncology, 2019, 33(6): 544-548.
[7]	FANG Xuan, CHEN Hongsheng, Li Guodong, LIU Ming. Advances in research on treatment of aberrant crypt foci [J]. Journal of Practical Oncology, 2019, 33(4): 376-379.
[8]	FANG Lin, LIU Chao, ZHANG Chunhui, ZHANG Yanqiao. Research status and treatment strategies of maintenance therapy for metastatic colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 173-178.
[9]	XING Zhichao, MAI Wei. Research progress on potential targets of liposarcoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 82-86.
[10]	TIAN Yang, WU Huaxing. Clinical application of ultra-fine nasal endoscopy in digestive tract stenosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 550-554.
[11]	WANG Peng, ZHOU Haitao, LIANG Jianwei, ZHOU Zhixiang. Misdiagnosis of mesenteric fibromatosis as recurrence after radical resection of rectal cancer:A report of one case with literature review [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 442-444.
[12]	WANG Yuan, SUN Yihua. Advance in the role of β-catenin in soft tissue tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 455-459.
[13]	ZHANG Li,FANG Kewei,YUE Xi,WANG Hong,YANG Hanfeng,XU Xiaoxue. Research progress of cryoablation for bone metastases [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 353-356.
[14]	LI Lin, LI Zhigao. The relationship between metformin and different molecular subtypes of breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 267-270.
[15]	HAN Xuejiao, LI Yanchun, SUN lichun, LU Hailing. Research progress of the relationship between 14-3-3ζ and malignant tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 543-547.

Clinical research progress of mucinous breast cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments